COMMUNIQUÉS West-GlobeNewswire

miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference
12/08/2019
BOULDER, Colo., Aug. 12, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, [...]
TYME Announces Abstracts Selected for Presentation at the European Society of Medical Oncology Congress 2019
12/08/2019
SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed at disrupting cancer metabolism in metastatic [...]
Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months
12/08/2019
– Two praliciguat Phase 2 studies for diabetic nephropathy and heart failure with preserved ejection fraction (HFpEF) on track for data readouts in Q4 2019 – – Phase 2 study of olinciguat in sickle cell disease on track [...]
Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
12/08/2019
Enrollment Continues for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD; Topline Data Expected First Half of 2020 Pipeline Expanded in Addiction Medicine with Cocaine Antidote TNX-1300 and Potential New [...]
Mustang Bio to Present at 11th Annual Bioprocessing Summit
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Salarius Pharmaceuticals CEO Issues Letter to Stockholders
12/08/2019
HOUSTON, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced that its chief executive officer, [...]
Daré Bioscience Receives QIDP Designation from the FDA for DARE-BV1 for the Treatment of Bacterial Vaginosis
12/08/2019
DARE-BV1 Phase 3 registrational trial initiation expected in 4th quarter 2019 SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that [...]
Generex Biotechnology Announces Update to the Previously Declared 1:1 Stock Dividend
12/08/2019
Filing of up-list application to Nasdaq New Dates Established for 1:1 Shareholder stock dividend New Record Date: August 30, 2019 Pay Date: October 30, 2019 Ex-Date: October 31, 2019 Dividend to be Paid to show [...]
Novadip Biosciences presents poster at 11th annual The Bioprocessing Summit
12/08/2019
Novadip Biosciences presents poster at 11 th annual The Bioprocessing Summit Presentation to focus on manufacturing platform for tissue engineering Mont-Saint Guibert, Belgium, 12 August 2019: Novadip Biosciences (“ [...]
Theratechnologies Files Application to List on NASDAQ
12/08/2019
MONTREAL, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) today announced that it has applied to list its common shares on NASDAQ. “We believe that being listed [...]
Theratechnologies soumet une demande d’inscription au NASDAQ
12/08/2019
MONTRÉAL, 12 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Compagnie ») (TSX: TH) a annoncé aujourd’hui avoir soumis une demande d’inscription de ses actions ordinaires au NASDAQ [...]
XOMA’s Royalty Portfolio Expands Significantly
12/08/2019
EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), today announced its portfolio of potential future royalty and milestone payments has significantly increased with the addition of [...]
Entasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
12/08/2019
WALTHAM, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Auxly Announces CEO Succession
12/08/2019
Effective August 27, 2019, Hugo Alves to become Chief Executive Officer (CEO) and Chuck Rifici to serve as Chairman of the Board of Directors VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis [...]
Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
12/08/2019
The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE [...]
Evolus Reports Second Quarter 2019 Financial Results
12/08/2019
Launched Jeuveau ® in the United States on May 15 Jeuveau ® Experience Treatment (J.E.T.) Program Exceeds Expectations Generated $2.3 Million in Jeuveau ® Net Revenue in Q2 2019 NEWPORT BEACH, Calif., Aug. 12, 2019 ( [...]
C-RAD and Mevion Release Integration for Improved Treatment Quality in Proton Therapy
12/08/2019
C-RAD and Mevion Medical Systems â announced today the integration between the C-RAD Catalyst PT™ and the MEVION S250i Proton Therapy System ® . The union of both products supports a seamless workflow with uninterrupted [...]
New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
12/08/2019
Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of life GAITHERSBURG, Md., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company [...]
Microbix Reports Results for Q3 Fiscal 2019
12/08/2019
Q3 Sales of $3.1 Million and $9.8 Million Year-To-Date TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for [...]

Pages